Variant report

Variant	nsv1028016
Chromosome Location	chr6:101001055-101158822
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:72)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:72 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr20:56283793..56286446-chr6:101062328..101064886,2	MCF-7	breast:
2	chr6:101115915..101118042-chr6:101119236..101121242,2	MCF-7	breast:
3	chr6:101144625..101146533-chr6:101150207..101152551,2	K562	blood:
4	chr6:101140450..101143009-chr6:101144554..101147348,2	MCF-7	breast:
5	chr6:101123862..101126267-chr6:101132298..101133807,2	K562	blood:
6	chr6:101081950..101083969-chr6:101086738..101088997,2	MCF-7	breast:
7	chr6:101041802..101044393-chr6:101056918..101059370,2	K562	blood:
8	chr6:100774621..100775576-chr6:101105387..101106278,3	MCF-7	breast:
9	chr6:100564262..100565210-chr6:101105116..101106264,3	K562	blood:
10	chr6:101139725..101141428-chr6:101141736..101143273,2	K562	blood:
11	chr6:101137250..101140625-chr6:101142166..101144758,3	K562	blood:
12	chr6:101103606..101105187-chr6:101110691..101113240,2	K562	blood:
13	chr6:101120240..101121939-chr6:101124928..101126557,2	K562	blood:
14	chr6:101066085..101068490-chr6:101073516..101076131,2	K562	blood:
15	chr6:101004586..101006305-chr6:101009165..101010725,2	MCF-7	breast:
16	chr6:101134397..101136126-chr6:101142181..101145050,2	K562	blood:
17	chr6:100927185..100927844-chr6:101105325..101105870,2	MCF-7	breast:
18	chr6:101155893..101159033-chr6:101162373..101164963,3	K562	blood:
19	chr6:101151355..101153775-chr6:101154853..101157255,2	K562	blood:
20	chr6:101153025..101154840-chr6:101159613..101162231,2	MCF-7	breast:
21	chr6:101103606..101105187-chr6:101110691..101113240,2	K562	blood:
22	chr6:101024034..101026560-chr6:101041460..101044362,2	K562	blood:
23	chr6:101151240..101154082-chr6:101158096..101159766,2	K562	blood:
24	chr6:101144625..101146533-chr6:101150207..101152551,2	K562	blood:
25	chr6:101137250..101140625-chr6:101142166..101144758,3	K562	blood:
26	chr6:101090896..101093112-chr6:101096818..101099684,2	K562	blood:
27	chr6:101016964..101018507-chr6:101018894..101020427,2	MCF-7	breast:
28	chr6:100315644..100316614-chr6:101111864..101112500,2	K562	blood:
29	chr6:100315907..100316622-chr6:101105335..101106035,2	K562	blood:
30	chr6:101057024..101059544-chr6:101398692..101400539,2	K562	blood:
31	chr6:100564237..100565179-chr6:101105285..101106695,9	MCF-7	breast:
32	chr6:101040719..101042241-chr6:101045134..101047250,2	K562	blood:
33	chr6:101073440..101076010-chr6:101092946..101094506,2	K562	blood:
34	chr6:101115915..101118042-chr6:101119236..101121242,2	MCF-7	breast:
35	chr6:100559670..100561904-chr6:101108976..101110745,2	MCF-7	breast:
36	chr6:101139725..101141428-chr6:101141736..101143273,2	K562	blood:
37	chr6:101017900..101019505-chr6:101022464..101024601,2	K562	blood:
38	chr6:101040719..101042241-chr6:101045134..101047250,2	K562	blood:
39	chr6:100323281..100325618-chr6:101011792..101014556,2	K562	blood:
40	chr6:101067158..101069268-chr6:101070159..101073076,2	K562	blood:
41	chr6:101081950..101083969-chr6:101086738..101088997,2	MCF-7	breast:
42	chr6:100933157..100934125-chr6:101104912..101105845,2	MCF-7	breast:
43	chr6:101134397..101137375-chr6:101141087..101145140,3	K562	blood:
44	chr6:101090896..101093112-chr6:101096818..101099684,2	K562	blood:
45	chr6:101024034..101026560-chr6:101041460..101044362,2	K562	blood:
46	chr6:100554526..100556212-chr6:101104828..101106229,8	MCF-7	breast:
47	chr6:101060989..101063700-chr6:101064166..101066010,2	K562	blood:
48	chr6:101151240..101154082-chr6:101158096..101159766,2	K562	blood:
49	chr6:101060989..101063700-chr6:101064166..101066010,2	K562	blood:
50	chr6:101140450..101143009-chr6:101144554..101147348,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GRIK2-6	chr6:101080704-101080933	uc_202_+
2	lnc-SIM1-3	chr6:101080704-101080933	uc_202_-

No data

Variant related genes	Relation type
ENSG00000124225	chromatin interactions

Extended variants
information (count: 5719 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:5719 , 50 per page) page: 1 2 3 4 5 6 7 ... 115

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs150252021	chr6:101001101-101001102	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs536195397	chr6:101001171-101001172	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs554502140	chr6:101001220-101001221	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs572604756	chr6:101001231-101001232	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs569903122	chr6:101001238-101001239	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs190332938	chr6:101001242-101001243	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs138934870	chr6:101001275-101001276	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs576433440	chr6:101001276-101001277	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs543493197	chr6:101001313-101001314	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs78604637	chr6:101001315-101001316	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs181634062	chr6:101001321-101001322	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs371218849	chr6:101001374-101001375	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs12191092	chr6:101001416-101001417	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs541765422	chr6:101001455-101001456	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs183937441	chr6:101001456-101001457	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs143354265	chr6:101001462-101001463	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs554931656	chr6:101001518-101001519	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs552050708	chr6:101001525-101001526	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs569680679	chr6:101001534-101001535	Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs570547690	chr6:101001610-101001611	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs76578409	chr6:101001782-101001783	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs568499727	chr6:101001794-101001795	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs375292592	chr6:101001831-101001832	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs531333834	chr6:101001857-101001858	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs112600671	chr6:101001858-101001859	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs549886027	chr6:101001921-101001922	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs373052061	chr6:101001960-101001961	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs147455789	chr6:101002024-101002025	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs535499297	chr6:101002147-101002148	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs76175301	chr6:101002155-101002156	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs567375484	chr6:101002158-101002159	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs548120920	chr6:101002173-101002174	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs566208926	chr6:101002212-101002213	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs540047850	chr6:101002214-101002215	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs188707505	chr6:101002221-101002222	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs180828383	chr6:101002235-101002236	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs537192127	chr6:101002236-101002237	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs555435894	chr6:101002245-101002246	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs573698103	chr6:101002256-101002257	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs577532504	chr6:101002274-101002275	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs540983586	chr6:101002295-101002296	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs560411945	chr6:101002343-101002344	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs572217710	chr6:101002362-101002363	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs186094788	chr6:101002414-101002415	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs564159453	chr6:101002416-101002417	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs111707114	chr6:101002440-101002441	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs549906346	chr6:101002486-101002487	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs143846582	chr6:101002487-101002488	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs528912724	chr6:101002508-101002509	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs144269642	chr6:101002542-101002543	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Autism	22495311	CNVD
Gastric cancer	17908304	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Ependymoma	16718352	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Prostate cancer	18632612	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Urothelial carcinoma	18382360	CNVD
Ovarian neoplasms	16753589	CNVD
Hepatocellular carcinoma	16750200	CNVD
Wilms tumour	21544195	CNVD
Leukemia	18688285	CNVD
Prostate cancer	19242612	CNVD
Glioma	21046410	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Zellweger syndrome	21572526	CNVD
Follicular lymphoma	20505157	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Lung adenocarcinoma	21935476	CNVD
Prostate cancer	17245344	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Cancer	20164920	CNVD
Burkitt''s lymphoma	20823134	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Chondromyxoid Fibroma	20696777	CNVD
Cancer	21183584	CNVD
Developmental delay	19490664	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
small cell lung cancer	20016488	CNVD
Burkitt''s lymphoma	18698080	CNVD
Ovarian cancer	21720365	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	17170743	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21785460	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Myelofibrosis	22110671	CNVD
Obesity	21045960	CNVD
Liver carcinoma	19366792	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	16461572	CNVD
Neurocytoma	17123091	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Urothelial carcinoma	21177765	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD

Chromatin state (count:2089 , 50 per page) page: 1 2 3 4 5 6 7 ... 42

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:100960800-101035000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
2	chr6:100964200-101020000	Weak transcription	Duodenum Smooth Muscle	Duodenum
3	chr6:100965200-101011400	Weak transcription	Pancreas	Pancrea
4	chr6:100965400-101005000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
5	chr6:100965600-101033600	Weak transcription	Ovary	ovary
6	chr6:100966000-101002400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr6:100978200-101008200	Weak transcription	NHDF-Ad	bronchial
8	chr6:100978600-101019400	Weak transcription	HMEC	breast
9	chr6:100979800-101018200	Weak transcription	Primary T cells from cord blood	blood
10	chr6:100981800-101001400	Weak transcription	Brain Hippocampus Middle	brain
11	chr6:100986400-101005600	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
12	chr6:100988000-101019000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr6:100988200-101001800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr6:100988200-101018800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr6:100988200-101035000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
16	chr6:100988200-101035000	Weak transcription	GM12878-XiMat	blood
17	chr6:100988400-101005000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
18	chr6:100988800-101008400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
19	chr6:100988800-101034200	Weak transcription	Monocytes-CD14+_RO01746	blood
20	chr6:100989000-101018400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
21	chr6:100990600-101018200	Weak transcription	Left Ventricle	heart
22	chr6:100996800-101016000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr6:100997400-101008400	Weak transcription	NH-A	brain
24	chr6:100997600-101017000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr6:100997800-101015400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr6:100997800-101018000	Weak transcription	Dnd41	blood
27	chr6:100998000-101001200	Weak transcription	Muscle Satellite Cultured Cells	--
28	chr6:100998000-101001400	Weak transcription	A549	lung
29	chr6:100998000-101008200	Weak transcription	HSMM	muscle
30	chr6:100998000-101008600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr6:100998200-101015800	Weak transcription	Primary B cells from cord blood	blood
32	chr6:100999200-101001200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr6:101000800-101001600	Enhancers	Brain Cingulate Gyrus	brain
34	chr6:101000800-101002000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr6:101000800-101002600	Enhancers	Fetal Kidney	kidney
36	chr6:101001000-101001200	Enhancers	Fetal Heart	heart
37	chr6:101001000-101001200	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
38	chr6:101001000-101001400	Weak transcription	Fetal Intestine Small	intestine
39	chr6:101001000-101001600	Enhancers	Brain Angular Gyrus	brain
40	chr6:101001000-101001600	Enhancers	HSMMtube	muscle
41	chr6:101001000-101034000	Weak transcription	Fetal Intestine Large	intestine
42	chr6:101001200-101001400	Enhancers	Fetal Brain Male	brain
43	chr6:101001200-101001600	Enhancers	Muscle Satellite Cultured Cells	--
44	chr6:101001200-101001600	Enhancers	Brain Anterior Caudate	brain
45	chr6:101001200-101001600	Enhancers	Brain Germinal Matrix	brain
46	chr6:101001200-101001600	Active TSS	Pancreatic Islets	Pancreatic Islet
47	chr6:101001200-101001600	Enhancers	Sigmoid Colon	Sigmoid Colon
48	chr6:101001200-101001800	Enhancers	Brain Substantia Nigra	brain
49	chr6:101001200-101001800	Weak transcription	Fetal Heart	heart
50	chr6:101001200-101002000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links